E
EQRx
Biotech company aimed at creating less expensive medicine
About EQRx
EQRx is a biotechnology company focused on developing and delivering innovative medicines at significantly lower prices. The company aims to address the high cost burden of healthcare by creating a catalog of new medicines that are more affordable and accessible. EQRx operates in the pharmaceutical and healthcare markets, targeting disease areas with the highest cost burdens on society. The business model revolves around leveraging cutting-edge innovation and strategic collaborations to produce high-quality, cost-effective treatments. EQRx generates revenue by bringing these affordable medicines to market, thereby increasing access to essential healthcare solutions for a broader population. The company's clients include healthcare providers, patients, and payers who benefit from reduced costs and improved access to new treatments. EQRx's mission is to transform the healthcare system by making it more sustainable and equitable through innovative and affordable medical solutions.
Source: Dealroom company dataAt a glance
- Founded
- 2019
- Headquarters
- Cambridge, United States
- Listing
- Public via SPAC 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning EQRx.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Andreessen Horowitz
GV
ARCH Venture Partners
Arboretum Ventures- NVNextech Venture
Casdin Capital
Section 32
Nextech Invest
Series B and later13 investors entered at this stage
Verily
Boxer Capital
Mubadala Capital
Bain Capital Life Sciences- CMCorvex Management
Fidelity Investments
SoftBank
Invus
Rock Springs Capital
Franklin Templeton Investments
BVF Partners
Avidity Partners- CICM Life Sciences III
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about EQRx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EQRx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.